Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004019791 | SCV005015412 | uncertain significance | not specified | 2023-11-28 | criteria provided, single submitter | clinical testing | The c.94C>T (p.R32C) alteration is located in exon 1 (coding exon 1) of the RPL10L gene. This alteration results from a C to T substitution at nucleotide position 94, causing the arginine (R) at amino acid position 32 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Science for Life laboratory, |
RCV000149333 | SCV000088975 | unknown | Malignant tumor of prostate | no assertion criteria provided | not provided | Converted during submission to Uncertain significance. |